Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2019’, provides an overview of the Myasthenia Gravis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Myasthenia...
Global Markets Direct’s, ‘Birch Pollen Allergy - Pipeline Review, H1 2019’, provides an overview of the Birch Pollen Allergy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Birc...
Global Markets Direct’s, ‘House Dust Mite Allergy - Pipeline Review, H1 2019’, provides an overview of the House Dust Mite Allergy pipeline landscape.
The report provides comprehensive information on the therapeutics under development fo...
Global Markets Direct’s, ‘Pemphigus Vulgaris - Pipeline Review, H2 2018’, provides an overview of the Pemphigus Vulgaris pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pemphigu...
Global Markets Direct’s, ‘Lung Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Lung Transplant Rejection pipeline landscape.
The report provides comprehensive information on the therapeutics under developmen...
Global Markets Direct’s, ‘Anaphylaxis - Pipeline Review, H2 2018’, provides an overview of the Anaphylaxis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Anaphylaxis, complete ...
Global Markets Direct’s, ‘Kidney Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Kidney Transplant Rejection pipeline landscape.
The report provides comprehensive information on the therapeutics under develo...
Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H2 2018’, provides an overview of the Peanut Allergy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Peanut Allergy, ...
Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2018’, provides an overview of the Psoriasis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with a...
Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.
The report provides comprehensive information on the therapeutics un...
Global Markets Direct’s, ‘Liver Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Liver Transplant Rejection pipeline landscape.
The report provides comprehensive information on the therapeutics under developm...
Global Markets Direct’s, ‘Cedar Pollen Allergy - Pipeline Review, H2 2018’, provides an overview of the Cedar Pollen Allergy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Ceda...
Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.
The report provides comprehensive information on the therapeutics un...
Global Markets Direct’s, ‘Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2018’, provides an overview of the Granulomatosis with Polyangiitis (Wegener Polyangiitis) pipeline landscape.
The report provides co...
Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2018’, provides an overview of the Grass Pollen Allergy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Gras...